LOCAMEDIC H+ : revenue, balance sheet and financial ratios

LOCAMEDIC H+ is a French company founded 32 years ago, specialized in the sector Location et location-bail d'autres biens personnels et domestiques. Based in TOURS (37000), this company of category ETI shows in 2023 a revenue of 5.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LOCAMEDIC H+ (SIREN 393041470)
Indicator 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 5 396 311 € 5 173 961 € 4 504 514 € 4 129 151 € 3 398 490 € 3 247 418 € 2 623 369 € 2 173 716 €
Net income 389 399 € 452 418 € 309 257 € 260 687 € 172 341 € 172 308 € 189 891 € 91 725 €
EBITDA 459 913 € 603 771 € 427 798 € 339 522 € 205 081 € 221 103 € 196 700 € 100 612 €
Net margin 7.2% 8.7% 6.9% 6.3% 5.1% 5.3% 7.2% 4.2%

Revenue and income statement

In 2023, LOCAMEDIC H+ achieves revenue of 5.4 M€. Over the period 2016-2023, the company shows strong growth with a CAGR (compound annual growth rate) of +13.9%. Vs 2022: +4%. After deducting consumption (0 €), gross margin stands at 5.4 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 460 k€, representing 8.5% of revenue. Warning negative scissor effect: despite revenue change (+4%), EBITDA varies by -24%, reducing margin by 3.1 pts. This reflects costs rising faster than revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 389 k€, i.e. 7.2% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2023) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

5 396 311 €

Gross margin (2023) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

5 396 311 €

EBITDA (2023) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

459 913 €

EBIT (2023) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

440 204 €

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

389 399 €

EBITDA margin (2023) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

8.5%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 76%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Cash flow represents 7.0% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

76.234%

Cash flow / Revenue (2023) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

7.032%

Repayment capacity (2023) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.0

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

67.1%

Solvency indicators evolution
LOCAMEDIC H+

Sector positioning

Debt ratio
0.0 2023
2021
2022
2023
Q1: 0.0
Med: 10.94
Q3: 83.08
Excellent

In 2023, the debt ratio of LOCAMEDIC H+ (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
76.23% 2023
2021
2022
2023
Q1: 5.32%
Med: 32.76%
Q3: 61.66%
Excellent

In 2023, the financial autonomy of LOCAMEDIC H+ (76.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.0 years 2023
2021
2022
2023
Q1: 0.0 years
Med: 0.01 years
Q3: 1.45 years
Excellent

In 2023, the repayment capacity of LOCAMEDIC H+ (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 500.58. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.7x. Danger: operating income does not cover interest charges, unsustainable situation.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

500.577

Interest coverage (2023) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.684

Liquidity indicators evolution
LOCAMEDIC H+

Sector positioning

Liquidity ratio
500.58 2023
2021
2022
2023
Q1: 106.21
Med: 176.19
Q3: 306.8
Excellent +13 pts over 3 years

In 2023, the liquidity ratio of LOCAMEDIC H+ (500.58) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
0.68x 2023
2021
2022
2023
Q1: 0.0x
Med: 0.0x
Q3: 1.77x
Good -16 pts over 3 years

In 2023, the interest coverage of LOCAMEDIC H+ (0.7x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 57 days. Excellent situation: suppliers finance 57 days of the operating cycle (retail model). Overall, WCR represents 12 days of revenue, i.e. 185 k€ to permanently finance. Over 2016-2023, WCR increased by +1117%, requiring additional financing.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

185 201 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

57 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2023) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

12 j

WCR and payment terms evolution
LOCAMEDIC H+

Positioning of LOCAMEDIC H+ in its sector

Comparison with sector Location et location-bail d'autres biens personnels et domestiques

Valuation estimate

Based on 69 transactions of similar company sales (all years), the value of LOCAMEDIC H+ is estimated at 2 095 637 € (range 933 136€ - 4 409 925€). With an EBITDA of 459 913€, the sector multiple of 4.9x is applied. The price/revenue ratio is 0.40x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2023
69 tx
933k€ 2095k€ 4409k€
2 095 637 € Range: 933 136€ - 4 409 925€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
459 913 € × 4.9x
Estimation 2 260 749 €
970 401€ - 4 880 169€
Revenue Multiple 30%
5 396 311 € × 0.40x
Estimation 2 174 113 €
1 084 822€ - 3 391 176€
Net Income Multiple 20%
389 399 € × 4.0x
Estimation 1 565 146 €
612 447€ - 4 762 443€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 69 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Location et location-bail d'autres biens personnels et domestiques)

Compare LOCAMEDIC H+ with other companies in the same sector:

Voir toutes les statistiques du secteur Location et location-bail d'autres biens personnels et domestiques

Frequently asked questions about LOCAMEDIC H+

What is the revenue of LOCAMEDIC H+ ?

The revenue of LOCAMEDIC H+ in 2023 is 5.4 M€.

Is LOCAMEDIC H+ profitable?

Yes, LOCAMEDIC H+ generated a net profit of 389 k€ in 2023.

Where is the headquarters of LOCAMEDIC H+ ?

The headquarters of LOCAMEDIC H+ is located in TOURS (37000), in the department Indre-et-Loire.

Where to find the tax return of LOCAMEDIC H+ ?

The tax return of LOCAMEDIC H+ is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LOCAMEDIC H+ operate?

LOCAMEDIC H+ operates in the sector Location et location-bail d'autres biens personnels et domestiques (NAF code 77.29Z). See the 'Sector positioning' section above to compare the company with its competitors.